Meeting
2013 ASCO Annual Meeting
Rapid online feedback to improve clinical trial accrual: CODEL anaplastic glioma (AG) (NCCTG/Alliance N0577) as a model.
Authors
Holly Massett
National Cancer Institute, Rockville, MD
Holly Massett , Kurt A. Jaeckle , David M. Dilts , Andrea Denicoff , Erin Souhan , Jenny R Hopkins , Bhupinder Singh Mann
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Cancer Prevention/Epidemiology
Track
Cancer Prevention/Epidemiology
Sub Track
Epidemiology
Citation
J Clin Oncol 31, 2013 (suppl; abstr 1596)
DOI
10.1200/jco.2013.31.15_suppl.1596
Abstract #
1596
Poster Bd #
9A
Abstract Disclosures
Similar Posters
Poster
2019 ASCO Annual Meeting
Retrospective review for outcomes of IDH mutant, 1p/19q co-deleted gliomas based on initial treatment.
First Author: Christopher Ray Trevino
Poster
2013 ASCO Annual Meeting
Multicenter randomized phase II trial of methotrexate (MTX) and temozolomide (TMZ) versus MTX, procarbazine, vincristine, and cytarabine for primary CNS lymphoma (PCNSL) in the elderly: An Anocef and Goelams Intergroup study.
First Author: Antonio Marcilio Padula Omuro
First Author: Carlos Kamiya-Matsuoka
First Author: Marc C. Chamberlain